American Journal of Kidney Diseases
Volume 54, Issue 2 , Pages 345-360 , August 2009

Cardiovascular Disease in CKD in Children: Update on Risk Factors, Risk Assessment, and Management

  • Amy C. Wilson, MD, MS
    • ,
  • Mark M. Mitsnefes, MD, MS

      Affiliations

    • Corresponding Author InformationAddress correspondence to Mark M. Mitsnefes, MD, MS, Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, MLC: 7022, 3333 Burnet Ave, Cincinnati, OH 45229-3039

Received 18 February 2009 ,Accepted 17 April 2009.

References 

  1. National Kidney Foundation Task Force on Cardiovascular Disease. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? (What do we need to know? Special report from the National Kidney Foundation Task Force on Cardiovascular Disease). Am J Kidney Dis. 1998;32(suppl 3):S1–S121
  2. US Renal Data System: USRDS 2003 Annual Report. The National Institute of Diabetes and Digestive and Kidney Diseases. http://www.usrds.orgAccessed January 21, 2009
  3. McDonald SP, Craig JC Australian and New Zealand Paediatric Nephrology Association. Long-term survival of children with end-stage renal disease. N Engl J Med. 2004;350:2637–2639
  4. Mitsnefes M. Cardiovascular complications of pediatric chronic kidney disease. Pediatr Nephrol. 2008;23:27–39
  5. Mitsnefes MM, Ho P-L, McEnery PT. Hypertension and the progression of chronic renal insufficiency in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol. 2003;14:2618–2622
  6. Loirat C, Ehrich JH, Geerlings W, et al. Report on management of renal failure in children in Europe XXIII, 1992. Nephrol Dial Transplant. 1992;9(suppl 1):S26–S40
  7. Lerner GR, Warady BA, Sullivan EK, Alexander SR. Chronic dialysis in children and adolescents (The 1996 annual report of the North American Pediatric Renal Transplant Cooperative Study). Pediatr Nephrol. 1999;13:404–417
  8. Mitsnefes MM, Stablein D. Hypertension in pediatric patients on long-term dialysis: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis. 2005;45:309–315
  9. Smith JM, Ho PL, McDonald RA. Renal transplant outcomes in adolescents: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant. 2002;6:493–499
  10. Baluarte HJ, Gruskin AB, Ingelfinger JR, Stablein D, Tejani A. Analysis of hypertension in children post renal transplantation—A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol. 1994;8:570–573
  11. Mitsnefes MM, Khoury PR, McEnery PT. Early post transplant hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr. 2003;143:98–103
  12. Wilson AC, Greenbaum LA, Barletta GM, et al: High prevalence of the metabolic syndrome and associated left ventricular hypertrophy in pediatric renal transplant recipients [e-pub ahead of print]. Pediatr Transplant doi: 10.1111/j.1399-3046.2009.01141.x, accessed June 29, 2009
  13. Feber J, Wong H, Geier P, Chaudry B, Filler G. Complications of chronic kidney disease in children post-renal transplantation—A single center experience. Pediatr Transplant. 2008;12:80–84
  14. Flynn JT, Mitsnefes M, Pierce C, et al. Blood pressure in children with chronic kidney disease: A report from the Chronic Kidney Disease in Children Study. Hypertension. 2008;52:631–637
  15. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. Am J Kidney Dis. 2003;41:S22–S38(suppl 3)
  16. Querfeld U, Salusky IB, Nelson P, Fine RN. Hyperlipidemia in pediatric patients undergoing peritoneal dialysis. Pediatr Nephrol. 1988;2:447–452
  17. Querfeld U. Disturbances of lipid metabolism in children with chronic renal failure. Pediatr Nephrol. 1993;7:749–757
  18. Saland JM, Ginsberg H, Fisher EA. Dyslipidemia in pediatric renal disease: Epidemiology, pathophysiology, and management. Curr Opin Pediatr. 2002;14:197–204
  19. Silverstein DM, Palmer J, Polinsky MS, Braas C, Conley SB, Baluarte HJ. Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients. Pediatr Nephrol. 2000;14:105–110
  20. Milliner DS, Morgenstern BZ, Murphy M, Gonyea J, Sterioff S. Lipid levels following renal transplantation in pediatric recipients. Transplant Proc. 1994;26:112–114
  21. Chavers BM, Hardstedt M, Gillingham KJ. Hyperlipidemia in pediatric kidney transplant recipients treated with cyclosporine. Pediatr Nephrol. 2003;18:565–569
  22. Sgambat K, He J, McCarter RJ, Moudgil A. Lipoprotein profile changes in children renal transplantation in the modern immunosuppression era. Pediatr Transplant. 2008;12:796–803
  23. Silverstein DM, Mitchell M, LeBlanc P, Boudreaux JP. Assessment of risk factors for cardiovascular disease in pediatric renal transplant patients. Pediatr Transplant. 2007;11:721–729
  24. Saland JM, Pierce CB, Flynn JT, et al. Dyslipidemia in children with CKD: A report of the Chronic Kidney Disease in Children (CKiD) Study. 2008;Poster presented at: American Society of Nephrology Renal Week 2008, November 4-9, Philadelphia, PA
  25. Hanevold CD, Ho PL, Talley L, Mitsnefes MM. Obesity and renal transplant outcome: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics. 2005;115:352–356
  26. Mitsnefes MM, Khoury P, McEnery PT. Body mass index and allograft function in pediatric renal transplantation. Pediatr Nephrol. 2002;12:535–539
  27. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27:S5–S10(suppl 1)
  28. Prokai A, Fekete A, Kis E, et al. Post-transplant diabetes mellitus in children following renal transplantation. Pediatr Transplant. 2008;12:643–649
  29. Lai HL, Kartal J, Mitsnefes M. Hyperinsulinemia in pediatric patients with chronic kidney disease: The role of tumor necrosis factor-alpha. Pediatr Nephrol. 2007;22:1751–1756
  30. Lindblad YT, Axelsson J, Bárány P, et al. Hyperinsulinemia and insulin resistance, early cardiovascular risk factors in children with chronic kidney disease. Blood Purif. 2008;26:518–525
  31. Painter P, Krasnoff J, Mathias R. Exercise capacity and physical fitness in pediatric dialysis and kidney transplant patients. Pediatr Nephrol. 2007;22:1030–1039
  32. Weaver DJ, Kimball TR, Knilans T, et al. Decreased maximal aerobic capacity in pediatric chronic kidney disease. J Am Soc Nephrol. 2008;19:624–630
  33. Vandevoorde RG, Barletta GM, Chand DH, et al. Blood pressure control in pediatric hemodialysis: The Midwest Pediatric Nephrology Consortium Study. Pediatr Nephrol. 2007;22:547–553
  34. Ulinski T, Genty J, Viau C, Tillous-Borde I, Deschênes G. Reduction of left ventricular hypertrophy in children undergoing hemodialysis. Pediatr Nephrol. 2006;21:1171–1178
  35. Mitstnefes MM, Barletta GM, Dresner IG, et al. Severe cardiac hypertrophy and long-term dialysis: The Midwest Pediatric Nephrology Consortium Study. Pediatr Nephrol. 2006;21:1167–1170
  36. Fischbach M, Terzic J, Laugel V, et al. Daily on-line haemodiafiltration: A pilot trial in children. Nephrol Dial Transplant. 2004;19:2360–2367
  37. Fischbach M, Dheu C, Seuge L, Menouer S, Terzic J. In-center daily on-line hemodiafiltration: A 4-year experience in children. Clin Nephrol. 2008;69:279–284
  38. Fadrowski JJ, Pierce CB, Cole SR, Moxey-Mims M, Warady BA, Furth SL. Hemoglobin decline in children with chronic kidney disease: Baseline results from the Chronic Kidney Disease in Children Prospective Cohort Study. Clin J Am Soc Nephrol. 2008;3:457–462
  39. Staples AO, Wong CS, Smith JM, et al. Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:48–56
  40. Warady BA, Ho M. Morbidity and mortality in children with anemia at initiation of dialysis. Pediatr Nephrol. 2003;18:1055–1062
  41. El-Husseini AA, Sobh MA, Ghonheim MA. Complications of pediatric live-donor kidney transplantation: A single center's experience in Egypt. Pediatr Nephrol. 2008;23:2067–2073
  42. White CT, Schisler T, Er L, Djurdjev O, Matsuda-Abedini M. CKD following kidney transplantation in children and adolescents. Am J Kidney Dis. 2008;51:996–1004
  43. NAPRTCS. The NAPRTCS 2005 Annual Report. http://spitfire.emmes.com/study/ped/annlrept/annlrept2005.pdfAccessed February 10, 2009
  44. Bek K, Akman S, Bilge I, et al. Chronic kidney disease in children in Turkey. Pediatr Nephrol. 2009;24:797–806
  45. Jono S, Nishizawa Y, Shioi A, Morii H. 1,25-Dihydroxy-vitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation. 1998;98:1302–1306
  46. Menon S, Valentini RP, Hidalgo G, Peschansky L, Mattoo TK. Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease. Pediatr Nephrol. 2008;23:1831–1836
  47. Goldstein SL, Currier H, Watters L, Hempe JM, Sheth RD, Silverstein D. Acute and chronic inflammation in pediatric patients receiving hemodialysis. J Pediatr. 2003;143:653–657
  48. Cengiz N, Baskin E, Agras PI, Sezgin N, Saatci U. Relationship between chronic inflammation and cardiovascular risk factors in children on maintenance hemodialysis. Transplant Proc. 2005;37:2915–2917
  49. Sylvestre LC, Fonseca KP, Stinghen EA, Pereira AM, Meneses RP, Pecoits-Filho R. The malnutrition and inflammation axis in pediatric patients with chronic kidney disease. Pediatr Nephrol. 2007;22:864–873
  50. Goldstein SL, Leung JC, Silverstein DM. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: Effect of aspirin. Clin J Am Soc Nephrol. 2006;1:979–986
  51. Nurmohamed SA, Nube MJ. Reverse epidemiology: Paradoxical observations in haemodialysis patients. Neth J Med. 2005;63:376–381
  52. Silverstein DM. Inflammation in chronic kidney disease: Role in the progression of renal and cardiovascular disease [e-pub ahead of print]. Pediatr Nephrol. 2009;doi: 10.1007/s00467-008-1046-0, accessed June 29
  53. Johnstone LM, Jones CL, Grigg LE, Wilkinson JL, Walker RG, Powell HR. Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int. 1996;50:998–1006
  54. Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR. Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation. 2003;107:864–868
  55. Poyrazoglu HM, Düsünsel R, Narin F, et al. Homocysteine and left ventricular hypertrophy in children with chronic renal failure. Pediatr Nephrol. 2004;19:193–198
  56. Malikènas A, Cerniauskiene V, Jakutovic M, Jankauskiene A. Left ventricular geometry in children with chronic renal failure. Medicina. 2005;41:S5–S11(suppl 1)
  57. Matteucci MC, Wühl E, Picca S, et al. Left ventricular geometry in children with mild to moderate renal insufficiency. J Am Soc Nephrol. 2006;17:218–226
  58. Mitsnefes MM, Kimball TR, Kartal J, et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-Year follow-up study. J Pediatr. 2006;149:671–675
  59. Mitsnefes M, Flynn J, Cohn S, et al. Left ventricular hypertrophy and masked hypertension: A report from the Chronic Kidney Disease in Children (CKiD) cohort. 2008;Poster presented at: American Society of Nephrology Renal Week 2008, November 4-9, Philadelphia, PA
  60. Weaver DJ, Kimball TR, Koury PR, Mitsnefes MM. Cardiac output and associated left ventricular hypertrophy in pediatric chronic kidney disease. Pediatr Nephrol. 2009;24:565–567
  61. Drukker A, Urbach J, Glaser J. Hypertrophic cardiomyopathy in children with end-stage renal disease and hypertension. Proc Eur Dial Transplant Assoc. 1981;18:542–547
  62. Morris KP, Skinner JR, Wren C, Hunter S, Coulthard MG. Cardiac abnormalities in end stage renal failure and anaemia. Arch Dis Child. 1993;68:637–643
  63. Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF. Severe left ventricular hypertrophy in pediatric dialysis: Prevalence and predictors. Pediatr Nephrol. 2000;14:898–902
  64. Mitsnefes MM, Schwartz SM, Daniels SR, Kimball TR, Khoury P, Strife CF. Changes in left ventricular mass index in children and adolescents after renal transplantation. Pediatr Transplant. 2001;5:279–284
  65. Lumpaopong A, Tuntrakool C, Thirakhupt P, Chulamokha Y. Left ventricular hypertrophy and LV geometry in chronic dialysis children and adolescents. J Med Assoc Thai. 2005;88:S202–S205(suppl 3)
  66. Uçar T, Tutar E, Yalçinkaya F, et al. Global left-ventricular function by tissue Doppler imaging in pediatric dialysis patients. Pediatr Nephrol. 2008;23:779–785
  67. Becker-Cohen R, Nir A, Ben-Shalom E, et al. Improved left ventricular mass index in children after renal transplantation. Pediatr Nephrol. 2008;23:1545–1550
  68. Guízar-Mendoza JM, Amador-Licona N, Lozada EE, et al. Left ventricular mass and heart sympathetic activity after renal transplantation in children and young adults. Pediatr Nephrol. 2006;21:1413–1418
  69. Matteucci MC, Giordano U, Calzolari A, Turchetta A, Santilli A, Rizzoni G. Left ventricular hypertrophy, treadmill tests, and 24-hour blood pressure in pediatric transplant patients. Kidney Int. 1999;56:1566–1570
  70. El-Husseini AA, Sheashaa HA, Hassan NA, El-Demerdash FM, Sobh MA, Ghoneim MA. Echocardiographic changes and risk factors for left ventricular hypertrophy in children and adolescents after renal transplantation. Pediatr Transplant. 2004;8:249–254
  71. Kitzmueller E, Véscei A, Pichler J, et al. Changes of blood pressure and left ventricular mass in pediatric renal transplantation. Pediatr Nephrol. 2004;19:1385–1389
  72. Bullington N, Kartal J, Khoury P, Mitsnefes M. Left ventricular hypertrophy in pediatric kidney transplant recipients: Long-term follow-up study. Pediatr Transplant. 2006;10:811–815
  73. Muscheites J, Meyer AA, Drueckler E, et al. Assessment of the cardiovascular system in pediatric chronic kidney disease: A pilot study. Pediatr Nephrol. 2008;23:2233–2239
  74. Gruppen MP, Groothoff JW, Prins M, et al. Cardiac disease in young adult patients with end-stage renal disease since childhood: A Dutch cohort study. Kidney Int. 2003;63:1058–1063
  75. Goren A, Glaser J, Drukker A. Diastolic function in children and adolescents on dialysis and after kidney transplantation: An echocardiographic assessment. Pediatr Nephrol. 1993;7:725–728
  76. Mitsnefes MM, Kimball TR, Border WL, et al. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int. 2004;65:1461–1466
  77. Mitsnefes MM, Kimball TR, Border WL, et al. Abnormal cardiac function in children after renal transplantation. Am J Kidney Dis. 2004;43:721–726
  78. Saygili A, Yildirim SV, Cengiz N, Uslu Y, Tokel K, Saatçi U. Assessment of left ventricular diastolic function by Doppler tissue imaging in children with end-stage renal disease. Acta Paediatr. 2005;94:1055–1059
  79. Chinali M, deSimone G, Matteucci MC, et al. Reduced systolic myocardial function in children with chronic renal insufficiency. J Am Soc Nephrol. 2007;18:593–598
  80. Weaver DJ, Kimball T, Witt SA, et al. Subclinical systolic dysfunction in pediatric patients with chronic kidney disease. J Pediatr. 2008;153:565–569
  81. Groothoff JW, Gruppen MP, Offringa M, et al. Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol. 2002;13:2953–2961
  82. Oh J, Wunsch R, Turzer M, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106:100–110
  83. Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR. Abnormal carotid artery structure and function in children and adolescents with successful renal transplantation. Circulation. 2004;110:97–101
  84. Litwin M, Wühl E, Jourdan C, et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol. 2005;16:1494–1500
  85. Mitsnefes MM, Kimball TR, Kartal J, et al. Cardiac and vascular adaptation in pediatric patients with chronic renal disease: Role of calcium-phosphorus metabolism. J Am Soc Nephrol. 2005;16:2799–2803
  86. Briese S, Wiesner S, Will JC, et al. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease: Impact of calcium and vitamin D therapy. Nephrol Dial Transplant. 2006;21:1906–1914
  87. Poyrazoğlu HM, Düşünsel R, Yikilmaz A, et al. Carotid artery thickness in children and young adults with end stage renal disease. Pediatr Nephrol. 2007;22:109–116
  88. Shroff RC, Donald AE, Hiorns MP, et al. Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol. 2007;18:2996–3003
  89. Bilginer Y, Ozaltin F, Basaran CA, et al. Carotid intima-media thickness in children and young adults with renal transplant: Internal carotid artery vs. common carotid artery. Pediatr Transplant. 2007;11:888–894
  90. Van Summeren MJH, Hameleers JM, Schurgers LJ, et al. Circulating calcification inhibitors and vascular properties in children after renal transplantation. Pediatr Nephrol. 2008;23:985–993
  91. Litwin M, Wühl E, Jourdan C, et al. Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease. Nephrol Dial Transplant. 2008;23:2552–2557
  92. Ziolkowska H, Brzewski M, Roszkowska-Blaim M. Determinants of the intima-media thickness in children and adolescents with chronic kidney disease. Pediatr Nephrol. 2008;23:805–811
  93. Krmar RT, Balzano R, Jogestrand T, Cedazo-Minguez A, Englund MS, Berg UB. Prospective analysis of carotid arterial wall structure in pediatric renal transplants with ambulatory normotension and in treated hypertensive recipients. Pediatr Transplant. 2008;12:412–419
  94. Delucchi A, Dinamarca H, Gainza H, Whittle C, Torrealba I, Iñiguez G. Carotid intima-media thickness as a cardiovascular risk marker in pediatric end-stage renal disease patients on dialysis and in renal transplantation. Transplant Proc. 2008;40:3244–3246
  95. Milliner DS, Zinsmeister AR, Lieberman E, Landing B. Soft-tissue calcification in pediatric patients with end-stage renal disease. Kidney Int. 1990;38:931–936
  96. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478–1483
  97. Ishitani MB, Milliner DS, Kim DY, et al. Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients. Am J Transplant. 2005;5:1689–1693
  98. Civilibal M, Caliskan S, Adaletli I, et al. Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol. 2006;21:1426–1433
  99. Civilibal M, Caliskan S, Kurugoglu S, et al. Progression of coronary calcification in pediatric chronic kidney disease stage 5. Pediatr Nephrol. 2009;24:555–563
  100. Johnson HM, Douglas PS, Srinivasan SR, et al. Predictors of carotid intima-media thickness progression in young adults: The Bogalusa Heart Study. Stroke. 2007;38:900–905
  101. Litwin M, Niemirska A. Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol. 2009;24:709–719
  102. Shroff RC, McNair R, Figg N, et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 2008;118:1748–1757
  103. Kari J, Donald AE, Vallance DT, et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int. 1997;52:468–472
  104. Lilien MR, Schröder CH, Levtchenko EN, Koomans HA. Growth hormone therapy influences endothelial function in children with renal failure. Pediatr Nephrol. 2004;19:785–789
  105. Lilien MR, Stroes ES, Op't Roodt J, de Jongh S, Schröder CH, Koomans HA. Vascular function in children after renal transplantation. Am J Kidney Dis. 2003;41:684–691
  106. Lilien MR, Koomans HA, Schröder CH. Hemodialysis acutely impairs endothelial function in children. Pediatr Nephrol. 2005;20:200–204
  107. Wilson AC, Urbina E, Witt SA, Glascock BJ, Kimball TR, Mitsnefes M. Flow-mediated vasodilatation of brachial artery in children with chronic kidney disease. Pediatr Nephrol. 2008;23:1297–1302
  108. Kavey RW, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science: The Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation. 2006;114:2710–2738
  109. National Kidney Foundation. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis. 2004;43:S223–S229(suppl 1)
  110. Adolescents National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(suppl 4th report):S555–S576
  111. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease. Am J Kidney Dis. 2003;41:S61–S70(suppl 3)
  112. Kasiske B, Cosio FG, Beto J, et al. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: A report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant. 2004;4:S13–S53(suppl 7)
  113. Daniels SR, Greer FR Committee on Nutrition. Lipid Screening and Cardiovascular Health in Childhood. Pediatrics. 2008;122:198–208
  114. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. Am J Kidney Dis. 2000;35:S1–S140(suppl 2)
  115. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis. 2003;42:S1–S202(suppl 3)
  116. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis. 2006;47:S1–S146(suppl 3)
  117. National Kidney Foundation. Section III (State of the science: Novel and controversial topics in cardiovascular diseases, in K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients). Am J Kidney Dis. 2005;45:S76–S114(suppl 3)
  118. Nesrallah G, Suri R, Moist L, Kortas C, Lindsay RM. Volume control and blood pressure management in patients undergoing quotidian hemodialysis. Am J Kidney Dis. 2003;42:13–17
  119. Fagugli RM, Palumbo B, Ricciardi D, et al. Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients. Nephron Clin Pract. 2003;95:2322–2338
  120. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 2002;61:2235–2239
  121. Krmar RT, Berg UB. Blood pressure control in hypertensive pediatric renal transplants: Role of repeated ABPM following transplantation. Am J Hypertens. 2008;21:1093–1099
  122. Wiesbauer F, Heinze G, Mitterbauer C, Harnoncourt F, Hörl WH, Oberbauer R. Statin use is associated with prolonged survival of renal transplant recipients. J Am Soc Nephrol. 2008;19:2211–2218
  123. Serón D, Oppenheimer F, Pallardó LM, et al. Fluvastatin in the prevention of renal transplant vasculopathy: Results of a prospective, randomized, double-blind, placebo-controlled trial. Transplantation. 2008;15:82–87
  124. Hakim RM, Lowrie E. Obesity and mortality in ESRD: Is it good to be fat?. Kidney Int. 1999;55:1580–1581
  125. Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000;58:353-362
  126. Kopple JD. Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients. ASAIO J. 1997;43:246–250
  127. Nishizawa Y, Shoji T, Ishimura E. Body composition and cardiovascular risk in hemodialysis patients. J Ren Nutr. 2006;16:241–244
  128. Hanevold CD, Ho PL, Talley L, Mitsnefes MM. Obesity and renal transplant outcome: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics. 2005;115:352–356
  129. Mitsnsefes MM, Khoury P, McEnery PT. Body mass index and allograft function in pediatric renal transplantation. Pediatr Nephrol. 2002;17:535–539
  130. Hanafy S, Pinsk M, Jamali F. Effect of obesity on response to cardiovascular drugs in pediatric patients with renal disease. Pediatr Nephrol. 2009;24:815–821
  131. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005;28:S4–S36(suppl 1)

PII: S0272-6386(09)00760-4

doi: 10.1053/j.ajkd.2009.04.027

American Journal of Kidney Diseases
Volume 54, Issue 2 , Pages 345-360 , August 2009

Article Tools